According to Haemonetics's latest financial reports the company's current EPS (TTM) is HK$19.65. In 2022 the company made an earnings per share (EPS) of HK$14.59 an increase over its 2021 EPS that were of HK$3.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$19.85 | 36.04% |
2022 | HK$14.59 | 334.45% |
2021 | HK$3.36 | -79.77% |
2020 | HK$16.60 | 36.31% |
2019 | HK$12.18 | 75.47% |
2018 | HK$6.94 | -363.15% |
2017 | -HK$2.64 | -207.1% |
2016 | HK$2.46 | -132.17% |
2015 | -HK$7.66 | -268.43% |
2014 | HK$4.55 | -19.45% |
2013 | HK$5.64 | -15.28% |
2012 | HK$6.66 | -37.33% |
2011 | HK$10.63 | 8.73% |
2010 | HK$9.77 | -5.62% |
2009 | HK$10.36 | 15.09% |
2008 | HK$9.00 | 4.04% |
2007 | HK$8.65 | 28.9% |
2006 | HK$6.71 | -25.43% |
2005 | HK$9.00 | 49.68% |
2004 | HK$6.01 | 55% |
2003 | HK$3.88 | -21.88% |
2002 | HK$4.96 | 12.58% |
2001 | HK$4.41 | -1248.48% |
2000 | -HK$0.38 | -110.74% |
1999 | HK$3.58 | -379.39% |
1998 | -HK$1.28 | -243.48% |
1997 | HK$0.89 | -81.89% |
1996 | HK$4.93 |